Portal de Periódicos da CAPES

Autologous Tissue-engineered Osteochondral Graft for Talus Osteochondral Lesions

2011; Lippincott Williams & Wilkins; Volume: 10; Issue: 4 Linguagem: Inglês

10.1097/btf.0b013e318237c196

1538-1943

Celeste Scotti, André Leumann, Christian Candrian, Andrea Barbero, Davide Marco Croci, Dirk J. Schaefer, Marcel Jakob, Víctor Valderrábano, Iván Martín,

Knee injuries and reconstruction techniques

Current surgical treatments for osteochondral (OC) lesions of the talus typically result in a suboptimal fibrous/fibrocartilaginous repair tissue and in not-convincing clinical long-term results. Tissue-engineering strategies have the potential to overcome this limitation. These techniques are based on the use of a biomaterial that supports tissue growth, called “scaffold,” in both cell-free and cell-based approaches. Cell-free scaffolds have already entered clinical practice, but only short-term clinical data are available to date. Cell-based strategies already available for clinical use are limited to cartilage and are not yet suitable for OC regeneration. However, several engineered OC models have been reported in the literature and are currently under investigation. Most of the current and future strategies are designed for the regeneration of the knee articular surface, whereas the articular cartilage of the talus differs from that of the knee with respect to tissue morphology, biochemical composition, and biomechanical features. In this review, we will report some relevant current and experimental tissue-engineering strategies for OC lesions with a special focus on the regeneration of the articular surface of the talus.